In literature, elevated anti-TG6 levels have mainly been demonstrated in disorders predominantly involving the central nervous system (including amyotrophic lateral sclerosis and multiple sclerosis), perhaps suggesting anti-TG6 as an a-specific marker of central nervous system pathology [2, 36, 37]. This evidence concerns the gene TGM6 and multiple sclerosis.